Jian-Ming Hou
Overview
Explore the profile of Jian-Ming Hou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xue Y, Liu G, Ke D, Yu Y, Hou J
Exp Biol Med (Maywood)
. 2023 Sep;
248(20):1732-1744.
PMID: 37750023
Triiodothyronine (T3) is critical to osteogenesis, which is the key factor in bone growth. Our transcriptomic and metabolomic analysis results indicated that T3 leads to enhanced expression of G protein-coupled...
2.
Zhang Y, Zhang Z, Li N, Zhao L, Xue Y, Wu H, et al.
Biosci Biotechnol Biochem
. 2020 Mar;
84(6):1191-1200.
PMID: 32141386
The molecular mechanism of autophagy in Lactoferrin (LF) induced osteoblast differentiation is not fully demonstrated. In this study, alkaline phosphatase (ALP) activity, alizarin red S staining and ELISA were used...
3.
Hou J, Skovholt T
J Couns Psychol
. 2019 Dec;
67(3):386-400.
PMID: 31855023
This qualitative study aimed to explore characteristics that sustain therapists' resilience over years of practice. Ten highly resilient therapists were recruited during two phases of sample screening: peer nomination and...
4.
Chen X, Li Y, Zhang M, Chen Z, Ke D, Xue Y, et al.
J Mol Endocrinol
. 2019 May;
63(1):63-75.
PMID: 31125976
Lactoferrin (LF) is an iron-binding glycoprotein that plays an important role in promoting bone formation and inhibiting bone resorption; however, its effects on senile osteoporosis remain unknown. This study aimed...
5.
He M, Wang C, Sun J, Liu Y, Wang H, Zhao J, et al.
Biochem Pharmacol
. 2017 Apr;
137:51-60.
PMID: 28433552
Roscovitine is a selective CDK inhibitor originally designed as anti-cancer agent, which has also been shown to inhibit proliferation in vascular smooth muscle cells (VSMCs). However, its effect on vascular...
6.
Liu Y, Li Y, Chang H, Zhao J, Hou J, Yu K, et al.
J Cardiovasc Pharmacol
. 2016 Dec;
69(3):161-169.
PMID: 28009720
Purpose: Roscovitine (Rosc) is a selective inhibitor of cyclin-dependent kinases (CDKs) and a promising therapy for various cancers. However, limited information is available on the biological significance of Rosc in...
7.
Hou J, Chen E, Lin F, Lin Q, Xue Y, Lan X, et al.
Int J Endocrinol
. 2015 Aug;
2015:282806.
PMID: 26290662
Objectives. To investigate the role of the IGF-1R by which lactoferrin induces osteoblast growth. Methods. Osteoblast received 5 d lactoferrin intervention at a concentration of 0.1, 1, 10, 100, and...
8.
Hou J, Lin J, Wen J, Jin L, Tang F
Cell Immunol
. 2014 Oct;
292(1-2):53-6.
PMID: 25277607
Osteoclasts are bone-resorbing multinuclear cells derived from hematopoietic stem cells which are specialised to carry out lacunar bone resorption. The immunophenotype of giant cell-containing bone lesions in a wide range...
9.
Hou J, Wu M, Lin Q, Lin F, Xue Y, Lan X, et al.
Mol Biol Rep
. 2014 May;
41(8):5019-30.
PMID: 24792235
The aim of this study was to explore the effect of lactoferrin (LF) in primary fetal rat osteoblasts proliferation and differentiation and investigate the underlying molecular mechanisms. Primary rat osteoblasts...
10.
Hou J, Chen E, Wei S, Lin F, Lin Q, Lan X, et al.
Acta Pharmacol Sin
. 2014 Feb;
35(4):523-30.
PMID: 24562308
Aim: Excessive apoptosis of osteoblasts is the major cause of low bone mass, and bovine lactoferrin (bLF), an iron-binding glycoprotein, might protect osteoblastic cells from apoptosis induced by serum withdrawal....